FDA Import Refusal 112-1777626-2/1/3 — Glaxo Co
The FDA refused shipment 112-1777626-2/1/3 from Glaxo Co (Egypt) on Mar 18, 2008. The refused product falls under Drugs and Biologics — ANTI-HYPERTENSIVE N.E.C.. Cited charge: 75 This firm has 2 other import refusals on record.
Refusal Details
- Date
- Mar 18, 2008
- Country
- Egypt
- Product Category
- Drugs and Biologics
- Product Code
- 62CCP99 ANTI-HYPERTENSIVE N.E.C.
- Charges
- 75